NCT07321899ClinicalTrials.gov
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
باختصار
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
تدخّليةمطلوب 1,186 مشاركاً20 موقعاًدولة واحدة
الفئات
مسجَّلة في سجل واحد
- ClinicalTrials.govNCT07321899فتح هذا السجل في ClinicalTrials.govتمت المزامنة الأسبوع الماضي
يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.
تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.
هل أنت مهتم بهذه الدراسة؟
تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding7/20
Single-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 4 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,186 participants (target), run at 20 sites.
How this score is built
- Enrolment31/40
1,186 participants (target)
- Site count7/25
4 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 179 months
- Sponsor scale4/10
Medtronic Cardiovascular has led 19 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
ملخص
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
الحالات
- Severe Tricuspid Regurgitation
الأهلية
| الجنس | الجميع |
|---|---|
| الأعمار | 18 Years – لا حد أقصى |
| المتطوعون الأصحّاء | لا |
الأهلية كما كُتبت في السجل
الأهلية في عبارات بسيطة
لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.
تصميم الدراسة
| نوع الدراسة | تدخّلية |
|---|---|
| المرحلة | غير منطبق |
| التخصيص | معشّاة |
| نموذج التدخّل | PARALLEL |
| الغرض الأساسي | TREATMENT |
| التعمية | SINGLE (1) |
| التجنيد | مطلوب 1,186 مشاركاً |
الجهة الراعية والمتعاونون
- Medtronic Cardiovascular الجهة الراعية
الأذرع والتدخلات
- Medtronic Intrepid™ TTVREXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
- Edwards EVOQUE TTVRACTIVE_COMPARATOR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
- Single Arm RegistryEXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
التدخلات
- جهاز Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
- جهاز Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
مقاييس النتائج
مقياس النتيجة الأولي
Rate of Major Adverse Events (MAE)
الإطار الزمني 30-days post-procedure
مقياس النتيجة الأولي
Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention
الإطار الزمني 1-year post-procedure
مقياس النتيجة الثانوي
Tricuspid regurgitation (TR) grade reduction
Total number of patients with at least one grade TR reduction
الإطار الزمني 6 months post-procedure
مقياس النتيجة الثانوي
Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline
KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life
الإطار الزمني 6 months post-procedure
مقياس النتيجة الثانوي
All-cause mortality
الإطار الزمني 12 months post-procedure
مقياس النتيجة الثانوي
Heart failure hospitalization
الإطار الزمني 12 months post-procedure
مقياس النتيجة الثانوي
New onset conduction disturbance (NOCD)
الإطار الزمني 30 days post-procedure
مقياس النتيجة الثانوي
Total procedure time
الإطار الزمني Procedure
مقياس النتيجة الثانوي
Right ventricle (RV) dysfunction
الإطار الزمني 12 months post-procedure
التواريخ
| تاريخ البدء | 11 سبتمبر 2026 (فعلي) |
|---|---|
| الإتمام الأولي | 1 سبتمبر 2031 (تقديري) |
| الإتمام | 1 أبريل 2041 (تقديري) |
| أول نشر | 7 يناير 2026 (فعلي) |
| آخر تحديث | 12 نوفمبر 2026 |
| النتائج منشورة | غير مذكور في سجل السجل |
| آخر تأكيد للحالة | نوفمبر 2026 |
فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.
المواقع
20 موقعاً قيد التجنيد
United States
| المنشأة | المدينة | الولاية أو المنطقة | الحالة |
|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | قيد التجنيد |
| University of Alabama at Birmingham (UAB) Hospital | Birmingham | Alabama | قيد التجنيد |
| Buffalo General Medical Center | Buffalo | New York | قيد التجنيد |
| Northwestern Memorial Hospital | Chicago | Illinois | قيد التجنيد |
| The Christ Hospital | Cincinnati | Ohio | قيد التجنيد |
| Cleveland Clinic Foundation | Cleveland | Ohio | قيد التجنيد |
| Hartford Hospital | Hartford | Connecticut | قيد التجنيد |
| Cedars Sinai Medical Center | Los Angeles | California | قيد التجنيد |
| Northwell Health North Shore University Hospital | Manhasset | New York | قيد التجنيد |
| Abbott Northwestern Hospital | Minneapolis | Minnesota | قيد التجنيد |
| Morristown Medical Center | Morristown | New Jersey | قيد التجنيد |
| Yale New Haven Hospital | New Haven | Connecticut | قيد التجنيد |
| Montefiore Medical Center | New York | New York | قيد التجنيد |
| NYU Langone Medical Center | New York | New York | قيد التجنيد |
| The Valley Hospital | Paramus | New Jersey | قيد التجنيد |
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | قيد التجنيد |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | قيد التجنيد |
| Los Robles Hospital & Medical Center | Thousand Oaks | California | قيد التجنيد |
| Ascension Via Christi Saint Francis | Wichita | Kansas | قيد التجنيد |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | قيد التجنيد |
مستندات الدراسة
لا تُرتبط أي مستندات في سجل السجل هذا.
التغيّرات عبر الزمن
- 12 نوفمبر 2026
أُضيف موقع
7 sites added (20 total)
1320
- 25 سبتمبر 2026
أُضيف موقع
9 sites added (13 total)
413
- 28 يوليو 2026
تغيّرت الحالة
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28 يوليو 2026
فُتح التجنيد
Recruitment opened
NOT_YET_RECRUITINGRECRUITING
- 28 يوليو 2026
أُضيف موقع
4 sites added (4 total)
04